AAI appoints Anand Balasubramani as Chief Scientific Programs Officer

Balasubramani was Founding Editor of Science Immunology and joins AAI from the American Society for Microbiology

2026-03-11

(Press-News.org) The American Association of Immunologists (AAI) is pleased to announce the appointment of Anand Balasubramani, PhD, as its inaugural Chief Scientific Programs Officer (CSPO), effective March 25, 2026. This newly established executive role reflects AAI’s commitment to strengthening its scientific programming, expanding its thought leadership, and supporting the rapidly evolving field of immunology.

Dr. Balasubramani brings more than a decade of leadership experience in scientific publishing, program development, and community engagement across nonprofit scientific organizations. Balasubramani joins AAI from the American Society for Microbiology, where he most recently served as Journals Development Editor, leading the launch and growth of high-volume journals and building strategic initiatives and partnerships that advanced the society’s scientific mission. Earlier in his career, as Founding Editor of Science Immunology, he played a lead role in building the journal into a highly respected publication. His scientific background includes research in autoimmunity, cytokine biology, epigenetics, and leukemia.

In his new role as CSPO, Balasubramani will serve as a key member of the AAI senior leadership team, shaping the association’s scientific agenda and overseeing its publications, education, and scientific affairs portfolios. He will lead strategic initiatives, and work closely with AAI staff, Council, and members to ensure that AAI’s scientific programming reflects the breadth and impact of modern immunology—from fundamental discovery to clinical translation.

Loretta Doan, PhD, AAI Chief Executive Officer, welcomed the appointment:

“We are thrilled to welcome Dr. Balasubramani to AAI. His deep roots in the immunology community, exceptional leadership in scientific publishing, and strong strategic vision make him uniquely suited for this role. Anand brings both creativity and experience to scientific program development, and we are confident he will help AAI expand its impact during this exciting period of growth for the field and the organization.”

Dr. Balasubramani said:

“Immunology has evolved into a remarkably diverse discipline spanning discovery science, translational innovation, and therapies that are transforming patient care. I am honored to join AAI at such an exciting time for our field and look forward to working with its members and leaders to build programs that support this expanding community of scientists, clinicians, and healthcare professionals. As immunologists, we will continue our long tradition of advancing discovery and shaping the future of science and medicine.”

AAI created the CSPO role as part of its strategic effort to strengthen its scientific affairs portfolio, expand and modernize its scientific and educational programming, and reinforce its position as a leading voice in the global immunology community. Balasubramani will also play a key role in shaping new initiatives, supporting AAI’s international collaborations, and advancing priorities highlighted in the AAI Strategic Framework.

About the American Association of Immunologists (AAI)

The American Association of Immunologists is one of the world’s largest organizations of immunologists and scientists in related disciplines. AAI members are responsible for many of the most important biomedical discoveries of the past century, including life‑saving cancer immunotherapies, antibody therapies, transplant technologies, and vaccines. AAI supports scientists through knowledge dissemination, advocacy, education, and community building to advance the field of immunology and improve global health.

END

ELSE PRESS RELEASES FROM THIS DATE:

Prior authorization may hinder access to lifesaving heart failure medications

2026-03-11

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two critical heart failure drugs, a new study shows. Led by NYU Langone Health researchers, the analysis focused on angiotensin receptor-neprilysin inhibitors (ARNIs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are pillars of modern heart failure treatment. The drugs have no generic alternatives and can cost hundreds of dollars out of pocket. While they have been shown to substantially reduce the risk of death when added to standard therapy, ...

Scholars propose transparency, credit and accountability as key principles in scientific authorship guidelines

2026-03-11

Three principles - transparency, credit, and accountability – should form the foundation for “responsible authorship”, argues a working group comprising scholars, scientists and journal editors. In an article published March 10 in the Proceedings of the National Academy of Sciences (PNAS), the group, led by PLOS’ Chief Scientific Officer Veronique Kiermer, states that contributions worthy of authorship should be determined by who has accountability for the research, and that all who claim the credit implied by authorship must assume that accountability. Who ...

Jeonbuk National University researchers develop DDINet for accurate and scalable drug-drug interaction prediction

2026-03-11

Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug–drug interactions (DDIs), which can either enhance or decrease therapeutic effects or trigger adverse drug reactions (ADRs), potentially leading to longer hospital stays or even life-threatening outcomes. In recent years, researchers have increasingly turned to deep learning models to predict DDIs. Although these models often outperform traditional methods, they are usually tested under idealized conditions, in which training and test data are randomly split, failing to reflect real-world ...

IEEE researchers achieve 20x signal boost in cerebral blood flow monitoring with next-generation interferometric diffusing wave spectroscopy

2026-03-11

Cerebral blood flow is essential for normal brain function and often perturbed in neurological disease. If one shines a source of coherent light on perfused tissue, the detected speckles, or “grains” of light fluctuate, or “dance”, at a rate proportional to blood flow in the volume sampled by the light. In brain tissue, this concept can be harnessed to measure the cerebral blood flow index (CBFi). However, to date, implementations of this principle for noninvasive adult human brain monitoring—collectively known as diffuse correlation spectroscopy (DCS)—have achieved limited brain sensitivity. This is because the brain is 1–2 ...

IEEE researchers achieve low-power ultrashort mid-IR pulse compression

2026-03-11

Ultrashort mid-infrared (mid-IR) laser pulses are essential for applications such as molecular spectroscopy, nonlinear microscopy, and biomedical imaging, but their generation often relies on complex and power-intensive systems that are difficult to implement outside of specialized laboratories. These systems usually require high pump powers, elaborate optical setups, and precise alignment, which can limit their widespread adoption and practical use in everyday research and clinical settings. In a paper made available online on 28 November 2025 and published in Volume 62, Issue 1 of the IEEE Journal of Quantum Electronics on 01 February 2026, ...

Deep-sea natural compound targets cancer cells through a dual mechanism

2026-03-11

A collaborative research team led by Professor Kaori Sakurai at Tokyo University of Agriculture and Technology, together with Associate Professor Hiroaki Itoh and Professor Masayuki Inoue at Graduate School of Pharmaceutical Sciences, the University of Tokyo, has uncovered a previously unknown mechanism of action of yaku’amide B, a structurally complex peptidic natural product derived from deep-sea sponge found in the waters near Yakushima Island, Japan. Natural products often exhibit multifaceted biological activities due to their structural complexity, interacting transiently with multiple biomolecules. Yaku’amide B ...

Antibiotics can affect the gut microbiome for several years

2026-03-11

Antibiotic treatments can affect the composition of the community of bacteria living in the gut, known as the gut microbiome, for a long time. A new study shows that certain types of antibiotics can be linked to changes in the gut microbiome as long as four to eight years after treatment. The findings have now been published in the scientific journal Nature Medicine. Antibiotics can be life-saving in serious infections, but epidemiological studies have also indicated links between high antibiotic use and an increased risk of certain health conditions, such as type 2 diabetes and gastrointestinal infections. The reasons for ...

Study: Electrical stimulation can restore ability to move limbs, receive sensory feedback after spinal cord injury

2026-03-11

PROVIDENCE, R.I. [Brown University] — The effects of spinal cord injuries are complex and multifaceted. People lose not only the ability to control the movement of their limbs, but also the ability to receive sensory feedback from them. Both are critical to generate the coordinated movement involved in walking. Now, a team of researchers from Brown University, Rhode Island Hospital, and VA Providence Healthcare has shown progress in restoring two-way communication across a damaged site of the spinal cord. In a study in Nature ...

Rice scientists unveil new tool to watch quantum behavior in action

2026-03-11

Electron movement and structures described in quantum physics allow researchers to better understand how and why materials like superconductors behave as they do. Rice University researchers Jianwei Huang and Ming Yi have developed a new capability, magnetoARPES, building on angle-resolved photoemission spectroscopy (ARPES) that allows researchers to study quantum behaviors they have been unable to resolve using ARPES alone. MagnetoARPES adds a tunable magnetic field, external to the sample, to ARPES. This allows researchers to probe the full electronic response to a magnetic field, giving insights into why certain collective behaviors of electrons develop. Magnetic ...

Gene-based therapies poised for major upgrade thanks to Oregon State University research

2026-03-11

PORTLAND, Ore. – Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells. Findings of the study spearheaded by Oregon State University College of Pharmacy graduate student Antony Jozić were published today in Nature Biotechnology. When gene therapies enter a cell, they are often sent to lysosomes, the cell’s trash and recycling centers, where therapeutic genetic material is broken down ...

LAST 30 PRESS RELEASES:

Concrete sensor manufacturer Wavelogix receives $500,000 grant from National Science Foundation

California communities’ recovery time between wildfire smoke events is shrinking

Augmented reality job coaching boosts performance by 79% for people with disabilities

Medical debt associated with deferring dental, medical, and mental health care